Vitiligo under anti-programmed cell death-1 therapy is associated with increased survival in melanoma patients.
Nardin C, Jeand'heur A, Bouiller K, Valnet-Rabier MB, Dresco F, Castagna J, Mareschal A, Carlet C, Nerich V, Limat S, Puzenat E, Aubin F.
Nardin C, et al. Among authors: mareschal a.
J Am Acad Dermatol. 2020 Mar;82(3):770-772. doi: 10.1016/j.jaad.2019.11.017. Epub 2019 Nov 14.
J Am Acad Dermatol. 2020.
PMID: 31734192
No abstract available.